In his first year as Verizon CEO, Dan Schulman significantly improved postpaid customer growth and cash flow, with record profits and reduced churn. However, revenue growth remains modest at 1.5%, equipment sales declined, and the company carries $166 billion in debt. Schulman’s strategy includes cost cuts, AI contracts, and fiber expansion, but competition from satellite services like Starlink poses a threat. Investors will watch Verizon’s 2027 outlook and service revenue growth in the coming quarters.
Verizon Communications Inc (VZ) trades at USD 43.73 on Pluang as of Oct 28, 2026 21:51 WIB, down 0.46% for the day. Despite CEO Dan Schulman's efforts to boost customer growth and cash flow, the stock shows a cautious sentiment with 63% of Pluang orders selling and a dividend yield of 6.44%. Investors appear to weigh the company's $166 billion debt and competition from satellite services like Starlink against its solid market cap of $182.09 billion.
Several high-yield dividend stocks like AT&T, Ford, Verizon, Dominion Energy, CenterPoint Energy, and Kinder Morgan face challenges as their capital spending plans increase significantly. These spending commitments can strain free cash flow and debt ...
Verizon Communications reported strong Q3 results, surpassing profit expectations due to robust broadband subscriber growth and record broadband revenue. The company generated $7.8 billion in free cash flow and plans to continue growing dividends, of...
Verizon was upgraded to a buy due to record postpaid phone additions, rising free cash flow, and improved earnings guidance. The company reported 406,000 net postpaid phone adds in Q3, 8% adjusted EBITDA growth, and $7.8 billion in free cash flow, su...
Verizon is trading at under 7x EBITDA, indicating it is fundamentally undervalued despite strong operating performance and free cash flow. The company's service revenue and postpaid subscriber growth remain robust, with revenue declines mainly due to...
Parnassus Value Equity Fund (Investor Shares) posted a -1.38% return net of fees in the third quarter, underperforming the Russell 1000 Value Index, which rose 2.61%. The fund's largest positive contributors were Thermo Fisher, CME Group, NICE, Willi...
